Cloud Pharmaceuticals Announces Participation at Upcoming #Biotech, Life Sciences and Partnering Events

Company to present merits of computer-based drug design over traditional methods

Jan 06, 2016, 10:28 ET from Cloud Pharmaceuticals, Inc.

RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2016 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a cloud-based drug design and development company, has announced its participation at upcoming biotech, life sciences and partnering events. The company designs and develops new drugs for a wide range of therapeutic areas including oncology, CNS disorders, and cardiovascular/metabolic diseases. It partners extensively with for-profit, government, and academic organizations to jointly design and develop new drugs and then seeks to partner with later-stage developers.

Representatives of the company will be present at these events to discuss Cloud Pharmaceuticals' approach to drug design and development. This approach radically improves upon traditional drug discovery methods by combining cloud computing, quantum mechanics and molecular property simulation. The resulting drug candidates are prequalified for development, enabling faster progress at lower cost and a higher success rate.

J.P. Morgan Global Healthcare Conference
January 11–14, 2016              
San Francisco, Calif.
Participation level: Partnering
#JPM16

Biotech Showcase          
January 11, 2016              
San Francisco, Calif.
Participation level: Partnering
#BTS16

RESI San Francisco 2016
January 12, 2016
San Francisco, Calif.
Participation level: Partnering
#RESISF2016

Cavendish Global Impact Forum
February 15–17, 2016
Palm Beach, Fla.
Participation level: Attending
@CavendishGlobal

Biocom's Global Life Science Partnering Conference
February 24-25, 2016
La Jolla, Calif.
Participation level: Partnering
@BIOCOMCA

CED Life Science Conference
March 2, 2016   
Raleigh, N.C.
Participation level: Presenting
#CES2016

Cavendish Global Impact Forum
May 1, 2016
La Jolla, Calif.
Participation level: Attending
@CavendishGlobal

BioEquity Europe
May 10, 2016
Copenhagen, Denmark
Participation level: Partnering
@BioCentury

To learn more please visit www.cloudpharmaceuticals.com. To meet with a representative of Cloud Pharmaceuticals at an upcoming event, please email info@cloudpharmaceuticals.com.  

About Cloud Pharmaceuticals, Inc.

Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new medicines. The company's Quantum Molecular Design process designs drug candidates that are qualified for development from the outset, enabling faster progress at lower cost and a higher success rate. The company partners at all stages of drug development – from discovery through the clinic – and is building an extensive product pipeline that spans a wide range of indications. For information visit www.cloudpharmaceuticals.com.

SOURCE Cloud Pharmaceuticals, Inc.



RELATED LINKS

http://www.cloudpharmaceuticals.com